Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTAC degraders as chemical probes for studying target biology and target validation
Václav Nêmec, Martin P. Schwalm, Susanne Müller, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7971-7993
Closed Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

Rational Proteolysis Targeting Chimera Design Driven by Molecular Modeling and Machine Learning
Shuoyan Tan, Zhuo Chen, Ruiqiang Lu, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2025) Vol. 15, Iss. 2
Closed Access
PROTAC chemical probes for histone deacetylase enzymes
Urvashi Patel, Joshua P. Smalley, James T. Hodgkinson
RSC Chemical Biology (2023) Vol. 4, Iss. 9, pp. 623-634
Open Access | Times Cited: 9
Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design
Harish Kumar, M. Elizabeth Sobhia
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1306-1318
Closed Access | Times Cited: 3
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs
Georg E. Winter
ACS Chemical Biology (2024)
Open Access | Times Cited: 3
Characterizing the Cooperative Effect of PROTAC Systems with End-Point Binding Free Energy Calculation
Kexin Xu, Zhe Wang, Sutong Xiang, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 19, pp. 7666-7678
Closed Access | Times Cited: 3
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target Validation
Mary M. Mader, Joachim Rudolph, Ingo V. Hartung, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2150-2165
Open Access | Times Cited: 8
Bifunctional robots inducing targeted protein degradation
M. Elizabeth Sobhia, Harish Kumar, Sonia Kumari
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115384-115384
Closed Access | Times Cited: 7
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Stereochemical inversion at a 1,4-cyclohexyl PROTAC linker fine-tunes conformation and binding affinity
Martina Pierri, Xingui Liu, Alena Kroupova, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 110, pp. 129861-129861
Open Access | Times Cited: 2
High-Throughput Screening for LC3/GABARAP Binders Utilizing the Fluorescence Polarization Assay
Martin P. Schwalm, Johannes Dopfer, Stefan Knapp, et al.
Methods in molecular biology (2024), pp. 203-218
Closed Access | Times Cited: 2
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B
Gerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Targeting LC3/GABARAP for degrader development and autophagy modulation
Martin P. Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Toward effective Atg8‐based ATTECs: Approaches and perspectives
Martin P. Schwalm, Stefan Knapp, Vladimir V. Rogov
Journal of Cellular Biochemistry (2023) Vol. 125, Iss. 11
Open Access | Times Cited: 4
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors
Mladen Koravović, Anand Mayasundari, Gordana Tasić, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115246-115246
Open Access | Times Cited: 4
Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC
Nadja M. Pieper, Julia Schnell, Daniela Bruecher, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets
Martin P. Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Antibody-PROTAC Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 (RIPK2) in HER+ Cell Lines
Karina Chan, Preethi S. Sathyamurthi, Markus A. Queisser, et al.
(2023)
Open Access | Times Cited: 3
Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization
Martin P. Schwalm, Andreas Krämer, Anja Dölle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis
Yibing Wang, Jianan Zheng, Yun‐Ze Long, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115989-115989
Closed Access | Times Cited: 2
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators
Yingpeng Liu, Radosław P. Nowak, Jianwei Che, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 2, pp. 607-611
Closed Access
Biguanide-PROTACs: Modulating Mitochondrial Proteins in Pancreatic Cancer Cells
Julie Vatté, Véronique Bourdeau, Gerardo Ferbeyre, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Functional characterization of pathway inhibitors for the ubiquitin-proteasome system (UPS) as tool compounds for CRBN and VHL-mediated targeted protein degradation
Martin P. Schwalm, Amelie Menge, Lewis Elson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Targeting Epigenetic Readers Using Small Molecule Binders and PROTAC Degraders
Eleonora Boccia, Erica Gazzillo, Maria Giovanna Chini, et al.
Interdisciplinary cancer research (2024)
Closed Access
Covalency in PROTACs: Mechanisms and applications
Thomas Geiger, Radosław P. Nowak
Annual reports in medicinal chemistry (2024), pp. 39-61
Closed Access
Effects of Biguanide-PROTACs in Pancreatic Cancer Cells
Julie Vatté, Véronique Bourdeau, Gerardo Ferbeyre, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5329-5329
Open Access

Scroll to top